Target intelligence / Profile preview

U6 small nuclear RNA 522 pseudogene (RNU6-522P)

Target
RNU6-522P
Molecular classification
Pseudogene, Non-coding RNA pseudogene
01

Overview

**RNU6-522P** (U6 small nuclear RNA 522 pseudogene) is classified as a non-coding RNA pseudogene derived from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is an essential component of the spliceosome, which mediates the splicing of pre-mRNA in the nucleus of eukaryotic cells[3][1]. Pseudogenes like RNU6-522P represent non-functional, typically non-expressed genomic sequences that arose by duplication or retrotransposition of the functional U6 snRNA gene[2][4]. These pseudogenes are evolutionarily common and thought to play no major direct biological role, though they can provide insight into genome evolution and gene family history[3][2]. There is no evidence that RNU6-522P encodes a functional RNA or protein, interacts with drugs, serves as a disease biomarker, or constitutes a therapeutic target. It is not considered a receptor, enzyme, transporter, or any other classical drug target.

Other names
RNU6-522PRNA, U6 small nuclear 522pseudogene
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on U6 small nuclear RNA 522 pseudogene (RNU6-522P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U6 small nuclear RNA 522 pseudogene (RNU6-522P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call